Jazz Pharmaceuticals (JAZZ) Net Income towards Common Stockholders Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 60.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.85% |
| Dec 31, 2025 | 41.75% |
| Sep 30, 2025 | 155.50% |
| Jun 30, 2025 | -177.41% |
| Mar 31, 2025 | -161.07% |
| Dec 31, 2024 | 99.24% |
| Sep 30, 2024 | 85.12% |
| Jun 30, 2024 | 35.04% |
| Mar 31, 2024 | -28.32% |
| Dec 31, 2023 | -10.95% |
| Sep 30, 2023 | -0.48% |
| Jun 30, 2023 | -3.12% |
| Mar 31, 2023 | 34.73% |
| Dec 31, 2022 | -73.10% |
| Sep 30, 2022 | -29.38% |
| Jun 30, 2022 | -47.92% |
| Mar 31, 2022 | -59.25% |
| Dec 31, 2021 | -30.09% |
| Sep 30, 2021 | -32.59% |
| Jun 30, 2021 | -80.95% |
| Mar 31, 2021 | 36.45% |
| Dec 31, 2020 | -16.78% |
| Sep 30, 2020 | 32.63% |
| Jun 30, 2020 | 3.31% |
| Mar 31, 2020 | -56.36% |
| Dec 31, 2019 | -13.66% |
| Sep 30, 2019 | 4.73% |
| Jun 30, 2019 | 31.90% |
| Mar 31, 2019 | 4.34% |
| Dec 31, 2018 | 24.66% |
| Sep 30, 2018 | 19.42% |
| Jun 30, 2018 | 1.78% |
| Mar 31, 2018 | -13.14% |
| Dec 31, 2017 | 41.78% |
| Sep 30, 2017 | 35.28% |
| Jun 30, 2017 | 34.40% |
| Mar 31, 2017 | 43.02% |
| Dec 31, 2015 | 34.07% |
| Sep 30, 2015 | 512.58% |
| Jun 30, 2015 | 189.27% |
| Mar 31, 2015 | 209.62% |
| Jun 30, 2014 | 9.49% |
| Mar 31, 2014 | -84.59% |